Back to Journals » OncoTargets and Therapy » Volume 11

Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine

Total article views   Abstract views HTML views PDF downloads Totals
3,246 Dovepress* 2,707 285+ 453 2,992
PubMed Central* 0 254 112 254
Totals 2,707 539 565 3,246
*Since 19 April 2018
+Since July 2016

View citations on PubMed Central and Google Scholar